Related Experiment Videos
Recurrent glomerular diseases after renal transplantation
F Y Karakayali1, H Ozdemir, S Kivrakdal
1Department of General Surgery, Başkent University, Faculty of Medicine, Ankara, Turkey.
Transplantation Proceedings
|March 22, 2006
Summary
Recurrent glomerular diseases significantly reduce kidney transplant graft survival. The donor
Area of Science:
- Nephrology
- Transplantation Immunology
Background:
- Recurrent glomerular diseases are a major cause of kidney graft dysfunction.
- Improved transplant outcomes highlight the significance of recurrent diseases.
Purpose of the Study:
- To identify risk factors for recurrent glomerular diseases post-renal transplantation.
- To determine the incidence of recurrence and its impact on graft survival.
Main Methods:
- Retrospective analysis of 49 patients with glomerular diseases (MPGN, FSGS, SLE).
- Mean follow-up of 9.5 years.
Main Results:
- Recurrence observed in 30 of 49 patients, significantly impacting graft survival (41.3 months vs. 79.4 months).
- HLA haplotype B8 identified as the sole significant risk factor for recurrence.
- One patient experienced recurrence in their third transplant.
Conclusions:
- Recurrent glomerular disease is a significant post-transplant complication associated with reduced graft survival.
- Donor HLA type, specifically B8, may increase recurrence risk.
- Pre-transplant discussion of HLA-associated risks is crucial for donors and recipients.